CAMP4 Therapeutics Corporation

NASDAQ:CAMP

Biotechnology

Healthcare
$4.00 +2.42%

+$0.10 today

Market cap
$251.02M
Beta
0.08
P/E (TTM)
-2.8
EPS (TTM)
-$1.49
52W Low $1.31High $7.75

Volume 0.21M

Average 0.10M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$29.55M

FY 2025 · Annual

Investing Cash Flow

-$243,000.00

FY 2025 · Annual

Financing Cash Flow

$75.89M

FY 2025 · Annual

+5.9% YoY

Cash Flow Statement

USD
Metric
FY2021
Feb 2022
FY2022
Feb 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.99M)(44.19M)(49.29M)(51.79M)(80.4M)
Depreciation & Amortization22.8M878K1.68M1.7M1.64M
Deferred Income Tax00000
Stock-Based Compensation11.32M1.38M2.91M4.03M4M
Change in Working Capital1.59M373K(154K)(1.88M)13.01M
Accounts Receivables1.44M0000
Inventory5.16M0000
Accounts Payables0000(1.03M)
Other Working Capital(5.01M)373K(154K)(1.88M)14.04M
Other Non-Cash Items(11.94M)3.02M705K2.39M32.21M
Operating Cash Flow(4.22M)(38.54M)(44.16M)(45.56M)(29.55M)
Capital Expenditures(13.3M)(4.03M)(678K)(441K)(279K)
Acquisitions (Net)000036K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities5.72M0000
Investing Cash Flow(7.58M)(4.03M)(678K)(441K)(243K)
Debt Repayment—(93K)116K(824K)(208K)
Common Stock Issued000061.17M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(2.64M)100.25M185K72.49M14.93M
Financing Cash Flow(2.64M)100.16M301K71.66M75.89M
Effect of Forex Changes(965K)25.6M000
Net Change in Cash(15.4M)83.19M(44.53M)25.66M46.09M
Free Cash Flow(17.52M)(42.57M)(44.83M)(46M)(29.83M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$80.4M
+ D&A$1.6M
+ Stock-Based Comp$4.0M
+ Deferred Tax$0
+ Working Capital$13.0M
+ Other Non-Cash$32.2M
= Operating Cash Flow-$29.6M
- Capex-$279.0K
= Free Cash Flow-$29.8M

Analysis

FY2025 free cash flow is -$29.8M. FCF conversion is 37.1% of net income. Operating cash flow was -$29.6M, with capex of -$279.0K. The largest bridge item is Other Non-Cash at $32.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13GSC 13G filingNov 12, 2026
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026

Does CAMP generate free cash flow?

CAMP4 Therapeutics Corporation (CAMP) generated -$29.83M of free cash flow in fiscal 2025.

How much operating cash flow does CAMP produce?

Operating cash flow was -$29.55M, before capital expenditures of $279,000.00.